Market research reports, consulting: Global Market Insights Inc.

Home > Healthcare > Medical Devices > Diagnostic Devices > preventive healthcare technologies and services market

Preventive Healthcare Technologies and Services Market Share

Report ID: GMI7106 Published Date: October 2023Report Format: PDF
Download Free Sample
Summary
Table of Content

Preventive Healthcare Technologies and Services Market Share

The preventive healthcare technologies and services industry is consolidated in nature, with major companies competing to offer superior products in this business space. Prominent players such as Teladoc Health, holds a significant share in the market. These companies are diligently directing their efforts towards continuous product innovation to gain substantial market share. For instance, Teladoc Health, introduced the Chronic Care Complete, a first-of-its-kind chronic condition management solution to help individuals recover their health outcomes.

Some of the eminent market participants operating in the preventive healthcare technologies and services industry include:

  • GlaxoSmithKline
  • Omnicell, Inc
  • Myriad Genetics
  • Omron Healthcare
  • Abbott Laboratories
  • Medtronic
  • Quest Diagnostics
  • Merck & Co. Inc.
  • Sanofi
  • NOVX Systems Corp
  • Moderna, Inc
  • Pfizer
  • Teladoc Health         
  • McKesson Corporation
  • Practice Fusion Inc.
Author: Mariam Faizullabhoy, Gauri Wani
Frequently Asked Question(FAQ) :

How is the demand for preventive healthcare technologies and services driven in hospitals?+

The hospitals end-use segment held over 41% of the preventive healthcare technologies and services industry share in 2022 propelled by the strong presence of skilled healthcare professionals.

How big is the preventive healthcare technologies and services market?+

Preventive healthcare technologies and services industry size was USD 251.2 billion in 2023 and is estimated to reach USD 605.3 billion by 2032 owing to the growing prevalence of chronic diseases, such as diabetes and obesity.

What is the value of the U.S. preventive healthcare technologies and services market?+

U.S. preventive healthcare technologies and services industry size was USD 70.9 billion in 2022 and is predicted to witness substantial growth through 2032 owing to rising technological advancements and substantial healthcare expenditure.

Who are the major preventive healthcare technologies and services industry players?+

GlaxoSmithKline, Omnicell, Inc, Myriad Genetics, Omron Healthcare, Abbott Laboratories, Medtronic, Quest Diagnostics, Merck & Co. Inc., Sanofi, NOVX Systems Corp and Moderna, Inc. are some of the key preventive healthcare technologies and service providers.

Preventive Healthcare Technologies and Services Market Scope

Related Reports

Buy Now

Premium Report Details

Download Free Sample